Twist Bioscience Corp. (TWST)
188.67
+0.62
(+0.33%)
USD |
NASDAQ |
Oct 02, 16:00
189.79
+1.12
(+0.59%)
After-Hours: 20:00
Twist Bioscience EPS Diluted (Quarterly) : -0.5617 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5617 |
| March 31, 2026 | -0.7134 |
| December 31, 2025 | -0.4995 |
| September 30, 2025 | -0.4491 |
| June 30, 2025 | 0.3334 |
| March 31, 2025 | -0.6593 |
| December 31, 2024 | -0.534 |
| September 30, 2024 | -0.5918 |
| June 30, 2024 | -1.472 |
| March 31, 2024 | -0.7873 |
| December 31, 2023 | -0.748 |
| September 30, 2023 | -0.8073 |
| June 30, 2023 | -1.006 |
| March 31, 2023 | -1.042 |
| December 31, 2022 | -0.741 |
| September 30, 2022 | -0.9084 |
| June 30, 2022 | -1.075 |
| March 31, 2022 | -1.135 |
| December 31, 2021 | -0.9129 |
| September 30, 2021 | -0.8357 |
| Date | Value |
|---|---|
| June 30, 2021 | -0.8177 |
| March 31, 2021 | -0.7785 |
| December 31, 2020 | -0.7152 |
| September 30, 2020 | -0.5431 |
| June 30, 2020 | -0.6742 |
| March 31, 2020 | -0.8548 |
| December 31, 2019 | -1.687 |
| September 30, 2019 | -0.9573 |
| June 30, 2019 | -0.9216 |
| March 31, 2019 | -0.9298 |
| December 31, 2018 | -1.180 |
| September 30, 2018 | -0.7442 |
| June 30, 2018 | -0.6442 |
| March 31, 2018 | -0.6167 |
| December 31, 2017 | -0.619 |
| September 30, 2017 | -0.6217 |
| June 30, 2017 | -0.5233 |
| March 31, 2017 | -0.5281 |
| December 31, 2016 | -0.4947 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -1.176 |
| Intellia Therapeutics, Inc. | -0.7989 |
| Prime Medicine, Inc. | -0.2376 |
| Absci Corp. | -0.2109 |
| 10X Genomics, Inc. | -0.138 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.05M |
| Revenue (Quarterly) | 118.38M |
| Total Expenses (Quarterly) | 153.43M |
| Enterprise Value | 11.75B |
| Gross Profit Margin (Quarterly) | 52.76% |
| Profit Margin (Quarterly) | -29.61% |
| Earnings Yield | -1.18% |
| Normalized Earnings Yield | -1.135 |